131 related articles for article (PubMed ID: 9120545)
1. Treatment of recurrent malignant supratentorial gliomas with the association of carboplatin and etoposide: a phase II study.
Ameri A; Poisson M; Chauveinc L; Chen QM; Delattre JY
J Neurooncol; 1997 Apr; 32(2):155-60. PubMed ID: 9120545
[TBL] [Abstract][Full Text] [Related]
2. Treatment of recurrent malignant supratentorial gliomas with ifosfamide, carboplatin and etoposide: a phase II study.
Sanson M; Ameri A; Monjour A; Sahmoud T; Ronchin P; Poisson M; Delattre JY
Eur J Cancer; 1996 Dec; 32A(13):2229-35. PubMed ID: 9038603
[TBL] [Abstract][Full Text] [Related]
3. Treatment of recurrent malignant supratentorial astrocytomas with carboplatin and etoposide combined with recombinant mutant human tumor necrosis factor-alpha.
Yamamoto M; Oshiro S; Tsugu H; Hirakawa K; Ikeda K; Soma G; Fukushima T
Anticancer Res; 2002; 22(4):2447-53. PubMed ID: 12174942
[TBL] [Abstract][Full Text] [Related]
4. Combination chemotherapy using carboplatin (JM-8) and etoposide (JET therapy) for recurrent malignant gliomas: a phase II study.
Watanabe K; Kanaya H; Fujiyama Y; Kim P
Acta Neurochir (Wien); 2002 Dec; 144(12):1265-70; discussion 1270. PubMed ID: 12478337
[TBL] [Abstract][Full Text] [Related]
5. Treatment of recurrent malignant supratentorial gliomas with carboplatin (CBDCA).
Poisson M; Péréon Y; Chiras J; Delattre JY
J Neurooncol; 1991 Apr; 10(2):139-44. PubMed ID: 1654401
[TBL] [Abstract][Full Text] [Related]
6. Treatment of recurrent malignant supratentorial gliomas with the association of procarbazine, thiotepa and vincristine: a phase II study.
Ameri A; Poisson M; Chen QM; Delattre JY
J Neurooncol; 1993 Jul; 17(1):43-6. PubMed ID: 8120571
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of prolonged oral therapy with etoposide (VP16) for patients with recurrent malignant glioma.
Fulton D; Urtasun R; Forsyth P
J Neurooncol; 1996 Feb; 27(2):149-55. PubMed ID: 8699237
[TBL] [Abstract][Full Text] [Related]
8. Intra-arterial carboplatin and intravenous etoposide for the treatment of recurrent and progressive non-GBM gliomas.
Newton HB; Slivka MA; Stevens CL; Bourekas EC; Christoforidis GA; Baujan MA; Chakeres DW
J Neurooncol; 2002 Jan; 56(1):79-86. PubMed ID: 11949830
[TBL] [Abstract][Full Text] [Related]
9. A phase II study of nimustine hydrochloride, cisplatin, and etoposide combination chemotherapy for supratentorial malignant gliomas.
Beppu T; Yoshida Y; Arai H; Wada T; Suzuki M; Ogawa A; Hakozaki S; Kubo N
J Neurooncol; 2000 Sep; 49(3):213-8. PubMed ID: 11212900
[TBL] [Abstract][Full Text] [Related]
10. Carboplatin and etoposide (CE) chemotherapy in patients with recurrent or progressive oligodendroglial tumors.
Scopece L; Franceschi E; Cavallo G; Paioli A; Paioli G; Conforti R; Palmerini E; Berzioli C; Spagnolli F; Esposti RD; Crinò L
J Neurooncol; 2006 Sep; 79(3):299-305. PubMed ID: 16645720
[TBL] [Abstract][Full Text] [Related]
11. [High dose chemotherapy with thiotepa, carboplatin, VP16 and autologous stem cell transplantation in treatment of malignant brain tumors with poor prognosis. Results of a mono-center pilot study].
Fleischhack G; Pöpping K; Hasan C; Utsch B; Jüttner J; Bode U
Klin Padiatr; 1998; 210(4):248-55. PubMed ID: 9743961
[TBL] [Abstract][Full Text] [Related]
12. Tamoxifen and carboplatin combinational treatment of high-grade gliomas. Results of a clinical trial on newly diagnosed patients.
Mastronardi L; Puzzilli F; Couldwell WT; Farah JO; Lunardi P
J Neurooncol; 1998 May; 38(1):59-68. PubMed ID: 9540058
[TBL] [Abstract][Full Text] [Related]
13. Carboplatin and etoposide chemotherapy regimen for recurrent malignant glioma: a phase II study.
Jeremic B; Grujicic D; Jevremovic S; Stanisavljevic B; Milojevic L; Djuric L; Mijatovic L
J Clin Oncol; 1992 Jul; 10(7):1074-7. PubMed ID: 1318951
[TBL] [Abstract][Full Text] [Related]
14. [Carboplatin and etoposide combination for the treatment of recurrent epithelial ovarian cancer].
Chauvergne J; Chinet-Charrot P; Stöckle E; Thomas L; Toulouse C
Bull Cancer; 1996 Apr; 83(4):315-23. PubMed ID: 8680083
[TBL] [Abstract][Full Text] [Related]
15. Combination chemotherapy with cisplatin, carboplatin, and etoposide in advanced malignancy: a phase I trial.
Rajkumar SV; Frytak S; Rubin J; Camoriano JK; Fitch TR
Am J Clin Oncol; 1997 Oct; 20(5):500-4. PubMed ID: 9345336
[TBL] [Abstract][Full Text] [Related]
16. Etoposide and carboplatin: a highly effective combination in relapsed or refractory Wilms' tumor--a phase II study by the French Society of Pediatric Oncology.
Pein F; Tournade MF; Zucker JM; Brunat-Mentigny M; Deville A; Boutard P; Dusol F; Gentet JC; Legall E; Mechinaud F
J Clin Oncol; 1994 May; 12(5):931-6. PubMed ID: 8164044
[TBL] [Abstract][Full Text] [Related]
17. A phase II trial of radiochemotherapy with daily carboplatin, after induction chemotherapy (carboplatin and etoposide), in locally advanced nonsmall-cell lung cancer: final analysis.
Bardet E; Rivière A; Charloux A; Spaeth D; Ducoloné A; Le Groumellec A; Pellae-Cosset B; Henry-Amar M; Douillard JY
Int J Radiat Oncol Biol Phys; 1997 Apr; 38(1):163-8. PubMed ID: 9212019
[TBL] [Abstract][Full Text] [Related]
18. High-dose carboplatin with etoposide in patients with recurrent thymoma: the Indiana University experience.
Hanna N; Gharpure VS; Abonour R; Cornetta K; Loehrer PJ
Bone Marrow Transplant; 2001 Sep; 28(5):435-8. PubMed ID: 11593315
[TBL] [Abstract][Full Text] [Related]
19. A phase II study of carboplatin and chronic high-dose tamoxifen in patients with recurrent malignant glioma.
Tang P; Roldan G; Brasher PM; Fulton D; Roa W; Murtha A; Cairncross JG; Forsyth PA
J Neurooncol; 2006 Jul; 78(3):311-6. PubMed ID: 16710748
[TBL] [Abstract][Full Text] [Related]
20. Temozolomide and oral VP-16 for children and young adults with recurrent or treatment-induced malignant gliomas.
Korones DN; Smith A; Foreman N; Bouffet E
Pediatr Blood Cancer; 2006 Jul; 47(1):37-41. PubMed ID: 16047359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
